Showing results (211-220 of 771) with videos related to
Sort By:
Pageof 78
The Journal of Clinical and Aesthetic Dermatology|December 6, 2013
Infrared camera evaluation of the cooling effect of triamcinolone acetonide aerosolRita V Linkner, Andrew Sohn, Kristin A Goldenberg, et al.Journal of Drugs in Dermatology : JDD|July 8, 2025
Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic KeratosisAlyssa M Roberts, Leon Kircik, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|August 9, 2023
Talquetamab-Induced Grover's DiseaseMindy Kresch, Sophie Guenin, Adnan Mubasher, et al.Plastic and Reconstructive Surgery|September 16, 2003
Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar linesJean D Carruthers, Nicolas J Lowe, M Alan Menter, et al.Journal of Drugs in Dermatology : JDD|March 5, 2020
Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in PsoriasisLawrence Green, Jeffrey M. Weinberg, Alan Menter, et al.Dermatology and Therapy|September 1, 2016
Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 StudiesAlan Menter, Jennifer C Cather, Michael Jarratt, et al.Journal of Drugs in Dermatology : JDD|February 3, 2009
Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasisAlan Menter, William Abramovits, Luz E Colón, et al.Journal of the American Academy of Dermatology|July 8, 2010
Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasisAlan Menter, Kenneth B Gordon, Craig L Leonardi, et al.Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regionsAlan Menter, Kim A Papp, Huaming Tan, et al.Journal of the American Academy of Dermatology|January 19, 2016
The spectrum of nephrocutaneous diseases and associations: Genetic causes of nephrocutaneous diseaseJay Wofford, Andrew Z Fenves, J Mark Jackson, et al.Pageof 78